Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE
- PMLiVE

Pharmaceutical Market Europe - February 2022

Charting patient pathways with precision for better healthcare, Fairer and faster access to medicines in the NHS, Greater price transparency

- PMLiVE

Pharmaceutical Market Europe - January 2022

Pharma congresses and conferences – virtual, hybrid or in-person? CVD: Europe’s hidden crisis; Research into autoimmune and inflammatory diseases

- PMLiVE

Pharmaceutical Market Europe - December 2021

Patient-centricity – the importance of face-to-face support; why AMR requires new, innovative and durable tools to treat microbial infections

- PMLiVE

Pharmaceutical Market Europe - November 2021

Achieving connected teamwork for patients and HCPs, the impact of corporate social responsibility, using digital technology for chronic conditions

- PMLiVE

Pharmaceutical Market Europe - October 2021

Time for pharma to ditch its cautious approach to creativity in comms, Alzheimer’s disease and beyond, Amarin is rethinking cardiovascular risk

- PMLiVE

Pharmaceutical Market Europe - September 2021

Celebrating a return to the live Communiqué Awards, Creating behaviour change through teamwork, Antimicrobial resistance: the silent epidemic

- PMLiVE

Pharmaceutical Market Europe - July/August 2021

Omnichannel communications, The importance of the patient voice in clinical trials, Hybrid working – making the new normal work for everyone

- PMLiVE

Pharmaceutical Market Europe - June 2021

Patient diversity in clinical trials, How the AMR Action Fund is combating antimicrobial resistance, Mastering the art of communications excellence

- PMLiVE

Pharmaceutical Market Europe - May 2021

Achieving a successful launch in a post-COVID-19 world, Alzheimer’s: the search for a cure, Rare diseases: why they can be so difficult to identify

- PMLiVE

Pharmaceutical Market Europe - April 2021

Are virtual congresses here to stay? How Italy is moving forward with digital therapeutics, EU cross-border healthcare for rare diseases

- PMLiVE

Pharmaceutical Market Europe - March 2021

Mapping the patient journey to improve support programmes, how UCB is treating severe disease, launching a new drug during a pandemic

- PMLiVE

Pharmaceutical Market Europe - February 2021

What’s in store for rare genetic diseases in 2021, why we need to prove precision medicine is cost-effective, looking at the remote working revolution